Interleukin-18 as a drug repositioning opportunity for inflammatory bowel disease: A Mendelian randomization study. (2019)

First Author: Mokry LE
Attributed to:  Mendelian randomization to hypothesis-free causal inference funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41598-019-45747-2

PubMed Identifier: 31253830

Publication URI: http://europepmc.org/abstract/MED/31253830

Type: Journal Article/Review

Volume: 9

Parent Publication: Scientific reports

Issue: 1

ISSN: 2045-2322